Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07393282
PHASE3

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Sponsor: Regeneron Pharmaceuticals

View on ClinicalTrials.gov

Summary

This study is researching an experimental drug called linvoseltamab (also called "study drug") compared to another drug called daratumumab, in participants with Smoldering Multiple Myeloma (SMM), who are at a High Risk (HR) of developing active multiple myeloma. The aim of this study is to find out whether linvoseltamab is better than daratumumab in delaying the development of MM. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)

Official title: A Phase 3, Randomized, Open-Label Study of Linvoseltamab Versus Daratumumab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

270

Start Date

2026-05-21

Completion Date

2033-07-27

Last Updated

2026-10-07

Healthy Volunteers

No

Interventions

DRUG

Linvoseltamab

Administered per the protocol

DRUG

Daratumumab

Administered per the protocol

Locations (20)

Mayo Clinic Phoenix, Mayo Clinic Building

Phoenix, Arizona, United States

Emory University - Winship Cancer Institute

Atlanta, Georgia, United States

Dana Farber / Harvard Cancer Center

Boston, Massachusetts, United States

Barbara Ann Karmanos Cancer Institute - Detroit

Detroit, Michigan, United States

Mayo Clinic

Rochester, Minnesota, United States

Washington University School of Medicine in St. Louis

St Louis, Missouri, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Ohio State University

Columbus, Ohio, United States

Nagoya City University Hospital

Nagoya, Aichi-ken, Japan

National Hospital Organization Okayama Medical Center

Okayama, Okayama-ken, Japan

Tokushima Prefectural Central Hospital

Tokushima, Tokushima, Japan

Yamanashi Prefectural Central Hospital

Kofu, Yamanashi, Japan

National Hospital Organization Matsumoto Medical Center

Matsumoto-shi, Japan

The Catholic University of Korea, St Vincents Hospital

Suwon, Gyeonggi-do, South Korea

Severance Hospital, Yonsei University Health System

Seoul, South Korea

Asan Medical Center

Seoul, South Korea

Seoul St. Mary's Hospital, The Catholic University of Korea

Seoul, South Korea

Royal Cornwall Hospital

Truro, Cornwall, United Kingdom

Norfolk and Norwich University Hospital

Norwich, Norfolk, United Kingdom

University Hospitals Leicester

Leicester, United Kingdom